Marinella VELTRONI
PUBBLICAZIONI
1: Gaipa G, Cazzaniga G, Valsecchi MG, Panzer-Grümayer R, Buldini B, Silvestri D, Karawajew L,
Maglia O, Ratei R, Benetello A, Sala S, Schumich A, Schrauder A, Villa T, Veltroni M, Ludwig WD,
Conter V, Schrappe M, Biondi A, Dworzak M, Basso G. Time point-dependent concordance of flow
cytometry and RQ-PCR in minimal residual disease detection in childhood acute lymphoblastic
leukemia. Haematologica. 2012 May 11.
2: Pillozzi S, Masselli M, De Lorenzo E, Accordi B, Cilia E, Crociani O, Amedei A, Veltroni M, D'Amico
M, Basso G, Becchetti A, Campana D, Arcangeli A. Chemotherapy resistance in acute lymphoblastic
leukemia requires hERG1 channels and is overcome by hERG1 blockers. Blood. 2011 Jan
20;117(3):902-14.
3: Dworzak MN, Gaipa G, Schumich A, Maglia O, Ratei R, Veltroni M, Husak Z, Basso G, Karawajew
L, Gadner H, Biondi A. Modulation of antigen expression in B-cell precursor acute lymphoblastic
leukemia during induction therapy is partly transient: Evidence for a drug-induced regulatory
phenomenon. Results of the AIEOP-BFM-FLOW-MRD-Study Group. Cytometry B Clin Cytom. 2010
Mar 3. [Epub ahead of print]
4: Buldini B, Zangrando A, Michielotto B, Veltroni M, Giarin E, Tosato F, Cazzaniga G, Biondi A,
Basso G. Identification of immunophenotypic signatures by clustering analysis in pediatric patients
with Philadelphia chromosome-positive acute lymphoblastic leukemia. Am J Hematol. 2010 Feb;
85(2):138-41.
5: Basso G, Veltroni M, Valsecchi MG, Dworzak MN, Ratei R, Silvestri D, Benetello A, Buldini B,
Maglia O, Masera G, Conter V, Arico M, Biondi A, Gaipa G. Risk of Relapse of Childhood Acute
Lymphoblastic Leukemia Is Predicted By Flow Cytometric Measurement of Residual Disease on Day
15 Bone Marrow. J Clin Oncol. 2009 Nov 1;27(31):5168-74.
6: Santoro A, Bica MG, Dagnino L, Agueli C, Salemi D, Cannella S, Veltroni M, Cetica V, Giarin E,
Fabbiano F, Basso G, Arico M. Altered mRNA expression of PAX5 is a common event in acute
lymphoblastic leukaemia. Br J Haematol. 2009 Jul 13.
7: Veltroni M, Sainati L, Zecca M, Fenu S, Tridello G, Testi AM, Merlone AD, Buldini B, Leszl A, Lo
Nigro L, Longoni D, Bernini G, Basso G; AIEOP-MDS Study Group. Advanced pediatric
myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic
and prognostic tool? Pediatr Blood Cancer. 2009 Mar;52(3):357-63.
8: Ratei R, Basso G, Dworzak M, Gaipa G, Veltroni M, Rhein P, Biondi A, Schrappe M, Ludwig WD,
Karawajew L; AIEOP-BFM-FCM-MRD-Study Group. Monitoring treatment response of childhood
precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with
multiparameter flow cytometry: predictive impact of early blast reduction on the remission status
after induction. Leukemia. 2009 Mar;23(3):528-34.
9: Dworzak MN, Gaipa G, Ratei R, Veltroni M, Schumich A, Maglia O, Karawajew L, Benetello A,
Pötschger U, Husak Z, Gadner H, Biondi A, Ludwig WD, Basso G. Standardization of flow cytometric
minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is
feasible. Cytometry B Clin Cytom. 2008 Nov;74(6):331-40.
10: Gaipa G, Basso G, Aliprandi S, Migliavacca M, Vallinoto C, Maglia O, Faini A, Veltroni M, Husak
D, Schumich A, Ratei R, Biondi A, Dworzak MN; I-BFM-ALL-FCM-MRD-Study Group. Prednisone
induces immunophenotypic modulation of CD10 and CD34 in nonapoptotic B-cell precursor acute
lymphoblastic leukemia cells. Cytometry B Clin Cytom. 2008 May;74(3):150-5.
11: Gaipa G, Basso G, Maglia O, Leoni V, Faini A, Cazzaniga G, Bugarin C, Veltroni M, Michelotto B,
Ratei R, Coliva T, Valsecchi MG, Biondi A, Dworzak MN; I-BFM-ALL-FCM-MRD Study Group. Druginduced immunophenotypic modulation in childhood ALL: implications for minimal residual
disease detection. Leukemia. 2005 Jan;19(1):49-56.
12: Veltroni M, De Zen L, Sanzari MC, Maglia O, Dworzak MN, Ratei R, Biondi A, Basso G, Gaipa G;
I-BFM-ALL-FCM-MRD-Study Group. Expression of CD58 in normal, regenerating and leukemic bone
marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic
leukemia. Haematologica. 2003 Nov;88(11):1245-52.
13: Bambi F, Fontanazza S, Messeri A, Lippi A, Tucci F, Tamburini A, Tintori V, Casini T, Lacitignola L,
Tondo A, Veltroni M, Bernini G, Faulkner LB. Use of percutaneous radial artery catheter for
peripheral blood progenitor cell collection in pediatric patients. Transfusion. 2003 Feb;43(2):254-8.
14: Sardi I, Tintori V, Marchi C, Veltroni M, Lippi A, Tucci F, Tamburini A, Bernini G, Faulkner L.
Molecular profiling of high-risk neuroblastoma by cDNA array. Int J Mol Med. 2002 May;9(5):5415.
15: Falcini F, Resti M, Azzari C, Simonini G, Veltroni M, Lionetti P. Acute febrile cholestasis as an
inaugural manifestation of Kawasaki's disease. Clin Exp Rheumatol. 2000 Nov-Dec;18(6):779-80.
16: Faulkner LB, Garaventa A, Paoli A, Tintori V, Tamburini A, Lacitignola L, Veltroni M, Lo Piccolo
MS, Viscardi E, Milanaccio C, Tondo A, Spinelli S, Bernini G, De Bernardi B. In vivo cytoreduction
studies and cell sorting—enhanced tumor-cell detection in high-risk neuroblastoma patients:
implications for leukapheresis strategies. J Clin Oncol. 2000 Nov 15;18(22):3829-36.
17: Lionetti P, Pupi A, Veltroni M, Fonda C, Cavicchi MC, Azzari C, Falcini F. Evidence of subclinical
intestinal inflammation by 99m technetium leukocyte scintigraphy in patients with HLA-B27
positive juvenile onset active spondyloarthropathy. J Rheumatol. 2000 Jun;27(6):1538-41.
18: Novembre E, Cianferoni A, Bernardini R, Veltroni M, Ingargiola A, Lombardi E, Vierucci A.
Epidemiology of insect venom sensitivity in children and its correlation to clinical and atopic
features. Clin Exp Allergy. 1998 Jul;28(7):834-8.
19: Bernardini R, Novembre E, Ingargiola A, Veltroni M, Mugnaini L, Cianferoni A, Lombardi E,
Vierucci A. Prevalence and risk factors of latex sensitization in an unselected pediatric population.
J Allergy Clin Immunol. 1998 May;101(5):621-5.